Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2025 | 04-2024 | 04-2023 | 04-2022 | 04-2021 | |
| Operating Expenses | 4,497 | 9,938 | 14,871 | 12,320 | 4,952 |
| Operating Income | -4,497 | -9,938 | -14,871 | -12,320 | -4,952 |
| Interest Expense | 18 | 10 | 8 | 47 | 159 |
| Other Income | 0 | 0 | 0 | 4 | 64 |
| Pre-tax Income | -4,515 | -9,948 | -14,878 | -12,362 | -5,047 |
| Net Income Continuous | -4,515 | -9,948 | -14,878 | -12,362 | -5,047 |
| Net Income | $-4,515 | $-9,948 | $-14,878 | $-12,362 | $-5,047 |
| EPS Basic Total Ops | -11.32 | -132.33 | -206.03 | -188.92 | -94.46 |
| EPS Basic Continuous Ops | -10.02 | -134.11 | -205.99 | -187.24 | -93.74 |
| EPS Diluted Total Ops | -11.32 | -132.33 | -206.03 | -188.92 | -94.46 |
| EPS Diluted Continuous Ops | -10.02 | -134.11 | -205.99 | -187.24 | -93.74 |
| EPS Diluted Before Non-Recurring Items | -11.32 | -132.31 | -202.42 | -188.92 | N/A |
| EBITDA(a) | $-4,446 | $-9,887 | $-14,847 | $-12,316 | $-4,952 |